Skip to content
healthcare.dev

Bupropion Hydrochloride SR

NDC 71335-0135, bupropion hydrochloride, tablet, film coated, extended release, from Bryant Ranch Prepack.

Product NDC
71335-0135
Status
Listed
Labeler
Bryant Ranch Prepack
Dosage form
TABLET, FILM COATED, EXTENDED RELEASE
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA079095
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/71335-0135 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • BUPROPION HYDROCHLORIDE150 mg/1

Pharmacologic classes

Aminoketone [EPC]; Dopamine Uptake Inhibitors [MoA]; Increased Dopamine Activity [PE]; Increased Norepinephrine Activity [PE]; Norepinephrine Uptake Inhibitors [MoA]

Package NDCNDC-11Package
71335-0135-17133501350160 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (71335-0135-1)
71335-0135-27133501350290 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (71335-0135-2)
71335-0135-37133501350330 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (71335-0135-3)
71335-0135-471335013504120 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (71335-0135-4)
71335-0135-57133501350545 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (71335-0135-5)
71335-0135-671335013506180 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (71335-0135-6)
71335-0135-77133501350728 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (71335-0135-7)
71335-0135-87133501350856 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (71335-0135-8)
71335-0135-971335013509100 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (71335-0135-9)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/ec8c699f-a8de-4e5a-a223-8de3f5dfe20d

Use it

Look up 71335-0135 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/71335-0135 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 71335-0135. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.